Healthcare Infection Control Practices Advisory Committee (HICPAC); Notice of Meeting and Request for Comment, 23964-23965 [2020-09133]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
23964
Federal Register / Vol. 85, No. 84 / Thursday, April 30, 2020 / Notices
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
through the use of appropriate
automated, electronic, mechanical, or
other technological collection
techniques or other forms of information
technology, e.g., permitting electronic
submission of responses.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before June 29, 2020. Write ‘‘Privacy
Rule: Paperwork Comment: FTC File
No. P085405’’ on your comment. Postal
mail addressed to the Commission is
subject to delay due to heightened
security screening. As a result, we
encourage you to submit your comments
online. To make sure that the
Commission considers your online
comment, you must file it through the
https://www.regulations.gov website by
following the instructions on the webbased form provided. Your comment,
including your name and your state—
will be placed on the public record of
this proceeding, including the https://
www.regulations.gov website.
If you file your comment on paper,
write ‘‘Privacy Rule: Paperwork
Comment: FTC File No. P085405’’ on
your comment and on the envelope, and
mail your comment to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW, Suite CC–
5610 (Annex J), Washington, DC 20580,
or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW,
5th Floor, Suite 5610, Washington, DC
20024. If possible, please submit your
paper comment to the Commission by
courier or overnight service.
Because your comment will be placed
on the public record, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
VerDate Sep<11>2014
18:56 Apr 29, 2020
Jkt 250001
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted on the https://
www.regulations.gov website—as legally
required by FTC Rule 4.9(b)—we cannot
redact or remove your comment, unless
you submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before June 29, 2020. For information on
the Commission’s privacy policy,
including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/
site-information/privacy-policy.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
[FR Doc. 2020–09158 Filed 4–29–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0042]
Healthcare Infection Control Practices
Advisory Committee (HICPAC); Notice
of Meeting and Request for Comment
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
SUMMARY: In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, limited only by audio phone
lines available. The public is welcome
to listen to the meeting by
teleconference at 1–800–369–1817, and
the passcode is 5200122; 200
teleconference lines are available.
Registration is required. Interested
parties may register at https://
www.cdc.gov/hicpac.
DATES: The meeting will be held on June
4, 2020, 9:00 a.m. to 3:00 p.m., EDT.
Written comments must be received
on or before May 21, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0042 by any of the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Koo-Whang Chung, M.P.H.,
Centers for Disease Control and
Prevention, l600 Clifton Road, NE, MS
H16–3, Atlanta, Georgia 30329–4027,
Attn: HICPAC meeting.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. Written
comments received in advance of the
meeting will be included in the official
record of the meeting.
Meeting information: The
teleconference access is 1–800–369–
1817, and the passcode is 5200122.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, l600 Clifton
Road NE, MS H16–3, Atlanta, Georgia
30329–4027; Telephone: 404–639–4000;
Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
E:\FR\FM\30APN1.SGM
30APN1
Federal Register / Vol. 85, No. 84 / Thursday, April 30, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Public Participation
Procedure for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Written Public Comment: The public
is welcome to submit written comments
in advance of the meeting. Comments
should be submitted on or before May
21, 2020. All requests must contain the
name, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
Comments received, including
attachments and other supporting
materials, are part of the public record
and are subject to public disclosure.
Comments will be posted on https://
www.regulations.gov. Therefore, do not
include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign. CDC will carefully
consider all comments submitted to the
docket.
Matters To Be Considered: The agenda
will include updates from the following
HICPAC workgroups: The Healthcare
Personnel Guideline Workgroup; the
Long-term Care/Post-acute Care
Workgroup; the National Healthcare
Safety Network Workgroup; and the
Bloodstream Infection Guideline
Workgroup. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
VerDate Sep<11>2014
18:56 Apr 29, 2020
Jkt 250001
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: April 24, 2020.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–09133 Filed 4–29–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0047]
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
SUMMARY: In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, limited only by audio phone
lines available. The public is welcome
to listen to the meeting by
teleconference; 200 teleconference lines
are available, and registration is
required.
The meeting will be held on May
15, 2020, 3 p.m.–4:30 p.m., EDT.
Written comments must be received
on or before May 13, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0047 by any of the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Koo-Whang Chung, M.P.H.,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H16–3, Atlanta, Georgia 30329–4027,
Attn: HICPAC meeting.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. Written
comments received in advance of the
DATES:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
23965
meeting will be included in the official
record of the meeting.
Meeting information: The
teleconference access is 1–800–857–
4261, and the passcode is 8109424.
Registration is required. Interested
parties may register at https://
www.cdc.gov/hicpac.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, 1600 Clifton
Road NE, MS H16–3, Atlanta, Georgia
30329–4027; Telephone: 404–639–4000;
Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Public Participation
Procedure for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Written Public Comment: The public
is welcome to submit written comments
in advance of the meeting. Comments
should be submitted on or before May
13, 2020. All requests must contain the
name and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
Comments received, including
attachments and other supporting
materials, are part of the public record
and are subject to public disclosure.
Comments will be posted on https://
www.regulations.gov. Therefore, do not
include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
E:\FR\FM\30APN1.SGM
30APN1
]]>Agencies
[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Pages 23964-23965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09133]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0042]
Healthcare Infection Control Practices Advisory Committee
(HICPAC); Notice of Meeting and Request for Comment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, limited only by audio phone lines available. The public is
welcome to listen to the meeting by teleconference at 1-800-369-1817,
and the passcode is 5200122; 200 teleconference lines are available.
Registration is required. Interested parties may register at https://www.cdc.gov/hicpac.
DATES: The meeting will be held on June 4, 2020, 9:00 a.m. to 3:00
p.m., EDT.
Written comments must be received on or before May 21, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0042 by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Koo-Whang Chung, M.P.H., Centers for Disease Control
and Prevention, l600 Clifton Road, NE, MS H16-3, Atlanta, Georgia
30329-4027, Attn: HICPAC meeting.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written comments received in advance of the meeting will be included in
the official record of the meeting.
Meeting information: The teleconference access is 1-800-369-1817,
and the passcode is 5200122.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE, MS H16-3, Atlanta, Georgia 30329-4027; Telephone: 404-639-
4000; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where
[[Page 23965]]
healthcare is provided; and (3) periodic updating of CDC guidelines and
other policy statements regarding prevention of healthcare-associated
infections and healthcare-related conditions.
Public Participation
Procedure for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Written Public Comment: The public is welcome to submit written
comments in advance of the meeting. Comments should be submitted on or
before May 21, 2020. All requests must contain the name, and
organizational affiliation of the speaker, as well as the topic being
addressed. Written comments should not exceed one single-spaced typed
page in length. Written comments received in advance of the meeting
will be included in the official record of the meeting. Comments
received, including attachments and other supporting materials, are
part of the public record and are subject to public disclosure.
Comments will be posted on https://www.regulations.gov. Therefore, do
not include any information in your comment or supporting materials
that you consider confidential or inappropriate for public disclosure.
If you include your name, contact information, or other information
that identifies you in the body of your comments, that information will
be on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted to
the docket.
Matters To Be Considered: The agenda will include updates from the
following HICPAC workgroups: The Healthcare Personnel Guideline
Workgroup; the Long-term Care/Post-acute Care Workgroup; the National
Healthcare Safety Network Workgroup; and the Bloodstream Infection
Guideline Workgroup. Agenda items are subject to change as priorities
dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Dated: April 24, 2020.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-09133 Filed 4-29-20; 8:45 am]
BILLING CODE 4163-18-P
